GO:0046949 fatty-acyl-CoA biosynthetic process: Lipid Metabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046949 (fatty-acyl-CoA biosynthetic process) describes the enzymatic formation of fatty-acyl-CoA thioesters, in which a fatty acid is activated by thioester linkage to the sulfhydryl group of coenzyme A.
• The reaction is catalyzed by acyl-CoA synthetases (ACSL, SLC27A, ACSBG families) and is essential for fatty acid trafficking into beta-oxidation, lipid synthesis, and signaling.
• Long-chain fatty acyl-CoA esters are not only metabolic intermediates but also potent signaling molecules that regulate AMPK, insulin sensitivity, and gene expression.
• Defects in fatty-acyl-CoA biosynthesis and downstream beta-oxidation cause inherited metabolic disorders such as acyl-CoA dehydrogenase deficiencies and peroxisomal diseases.
• CRISPR knockout, point-mutation, knock-in, and overexpression cell models enable causal dissection of ACSL/SLC27A gene function in fatty-acyl-CoA metabolism.
• Measuring acyl-CoA synthetase activity and acyl-CoA pools is central to metabolic, cancer, and neurodegeneration research.
Description
Fatty-acyl-CoA biosynthetic process (GO:0046949) is the biological process by which fatty acids are converted into fatty-acyl-CoA derivatives, in which the carboxyl group of a fatty acid is joined to the sulfhydryl group of coenzyme A through a thioester bond. This activation step is a prerequisite for nearly all downstream fatty acid utilization, including mitochondrial and peroxisomal beta-oxidation, glycerolipid and phospholipid synthesis, protein acylation, and lipid-mediated signal transduction. Because fatty-acyl-CoA esters sit at the crossroads of energy production, membrane biogenesis, and cellular signaling, the enzymes that generate them are of broad interest to researchers in metabolism, cancer, neurobiology, and inherited disease. The process is carried out primarily by acyl-CoA synthetase enzymes that ligate fatty acids of varying chain length to coenzyme A, and it is tightly coupled to fatty acid uptake and transport. Distinct enzyme families handle different substrate ranges and subcellular compartments, so the term encompasses reactions occurring in the cytosol, mitochondria, peroxisomes, and on membranes of the endoplasmic reticulum. The resulting acyl-CoA pool is dynamically partitioned between oxidation, storage, and signaling, a concept central to modern metabolic research. For experimental biologists, GO:0046949 provides a precise annotation target when studying lipid metabolism genes, and it is frequently used in functional enrichment analyses of transcriptomic and proteomic datasets. Understanding its mechanism, regulation, and disease links is therefore essential for designing rigorous CRISPR-based experiments and interpreting metabolic phenotypes.
fatty-acyl-CoA biosynthetic process At A Glance
| GO ID | GO:0046949 |
|---|---|
| GO term | fatty-acyl-CoA biosynthetic process |
| Ontology | biological_process |
| Synonym | fatty-acyl-CoA anabolism; fatty-acyl-CoA biosynthesis; fatty acyl CoA biosynthetic process; fatty-acyl-CoA formation; fatty-acyl-CoA synthesis |
| Major function | Activation of fatty acids by thioester linkage to coenzyme A, enabling beta-oxidation, lipid synthesis, protein acylation, and lipid signaling |
| Key enzymes | Acyl-CoA synthetase families including ACSL, SLC27A, and ACSBG proteins |
| Subcellular locations | Cytosol, mitochondria, peroxisomes, and endoplasmic reticulum membranes |
| Related metabolites | Long-chain fatty acyl-CoA esters, malonyl-CoA, and coenzyme A |
| Disease relevance | Inherited fatty acid oxidation disorders, insulin resistance, and peroxisomal disease |
What Is GO:0046949?
In simple terms, GO:0046949 describes the chemical reactions and pathways that build fatty-acyl-CoA molecules, which are fatty acids chemically linked to coenzyme A. The official QuickGO definition states that it is the chemical reactions and pathways resulting in the formation of a fatty-acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with a fatty-acyl group. This process activates fatty acids for subsequent metabolic use and is catalyzed mainly by acyl-CoA synthetases.
Why Is fatty-acyl-CoA biosynthetic process Important in Cell Biology?
Fatty-acyl-CoA biosynthetic process is important because it gates the entry of fatty acids into essentially every major lipid metabolic route, and because the acyl-CoA products themselves act as signaling molecules that influence energy sensing, insulin action, and gene regulation. Dysregulation of this process is linked to metabolic disease, inherited disorders of fatty acid oxidation, and altered cancer cell metabolism, making it a recurring focus of both basic and translational research.
• Provides activated fatty acyl-CoA substrates required for mitochondrial and peroxisomal beta-oxidation and ATP production.
• Supplies acyl-CoA building blocks for glycerolipid, phospholipid, and sphingolipid synthesis.
• Generates long-chain fatty acyl-CoA esters that regulate AMPK activity and cellular energy sensing.
• Contributes to insulin resistance mechanisms in skeletal muscle through malonyl-CoA and long-chain acyl-CoA accumulation.
• Supports protein acylation reactions such as palmitoylation that depend on fatty acyl-CoA donors.
• Is disrupted in inherited fatty acid oxidation disorders and peroxisomal biogenesis diseases.
• Influences cell signaling and transcriptional regulation via acyl-CoA-responsive pathways.
• Serves as a measurable metabolic readout in cancer and metabolic disease models.
• Is a common annotation in functional enrichment analyses of lipid metabolism datasets.
• Offers druggable and CRISPR-tractable nodes for metabolic pathway engineering.
What Happens During fatty-acyl-CoA biosynthetic process?
Fatty acid uptake and substrate presentation
In simple terms: First, the cell gets fatty acids to the enzyme that will activate them.
Fatty acids enter cells through membrane transport proteins and are delivered to acyl-CoA synthetases located in the cytosol, on mitochondria, on peroxisomes, and on the endoplasmic reticulum. The availability of free fatty acid substrate, together with transport and binding proteins, determines the rate at which fatty-acyl-CoA biosynthesis can proceed. Long-chain fatty acids are the predominant substrates in most mammalian tissues, and their delivery is closely coupled to the enzymes that activate them.
Thioester bond formation by acyl-CoA synthetases
In simple terms: The enzyme attaches coenzyme A to the fatty acid using energy from ATP.
Acyl-CoA synthetases catalyze the ATP-dependent ligation of a fatty acid to coenzyme A, forming a fatty-acyl-CoA thioester and releasing AMP and pyrophosphate. This two-step reaction proceeds through an acyl-adenylate intermediate before the fatty acyl group is transferred to the sulfhydryl group of coenzyme A. The resulting thioester bond is a high-energy linkage that activates the fatty acid for subsequent metabolism.
Chain-length specificity and compartmentalization
In simple terms: Different enzymes handle different fatty acid lengths in different parts of the cell.
Distinct acyl-CoA synthetase families exhibit preferences for short-, medium-, long-, and very-long-chain fatty acids, and they localize to different subcellular compartments. Peroxisomal acyl-CoA synthetases activate very-long-chain fatty acids for peroxisomal beta-oxidation, whereas mitochondrial and cytosolic enzymes handle long-chain species destined for oxidation or lipid synthesis. This division of labor allows the cell to route acyl-CoA products to appropriate downstream pathways.
Partitioning of the acyl-CoA pool
In simple terms: Once made, fatty-acyl-CoA can be burned for energy, stored as fat, or used as a signal.
Newly synthesized fatty-acyl-CoA esters are partitioned among beta-oxidation, esterification into complex lipids, and signaling functions. Malonyl-CoA and long-chain fatty acyl-CoA levels influence this partitioning and have been linked to insulin resistance in skeletal muscle. Long-chain fatty acyl-CoA esters also act as signaling molecules that regulate metabolism and gene expression.
Regulation by energy status and signaling kinases
In simple terms: The cell adjusts fatty-acyl-CoA production based on its energy needs.
The process is responsive to cellular energy status, with long-chain fatty acyl-CoA esters sensed by AMPK and other signaling components. Malonyl-CoA acts as both a substrate for fatty acid synthesis and a regulator of fatty acid oxidation, linking fatty-acyl-CoA biosynthesis to whole-body energy balance. These regulatory loops allow acyl-CoA production to match metabolic demand.
Key Genes Involved in GO:0046949 fatty-acyl-CoA biosynthetic process
The following genes encode enzymes, transporters, and regulatory proteins directly implicated in fatty-acyl-CoA biosynthetic process and its downstream biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACSL1 | Long-chain acyl-CoA synthetase activating fatty acids for oxidation and lipid synthesis | Metabolic disease, insulin resistance, and lipid flux studies |
| ACSL3 | Acyl-CoA synthetase associated with lipid droplet and membrane lipid synthesis | Lipid storage and cancer metabolism research |
| ACSL4 | Long-chain acyl-CoA synthetase involved in phospholipid remodeling | Ferroptosis and cancer cell death studies |
| ACSL5 | Acyl-CoA synthetase linked to endoplasmic reticulum lipid metabolism | Lipoprotein and hepatic lipid research |
| ACSL6 | Long-chain acyl-CoA synthetase enriched in brain and muscle | Neurometabolism and fatty acid utilization studies |
| SLC27A1 | Fatty acid transport protein with acyl-CoA synthetase activity | Fatty acid uptake and metabolic phenotyping |
| SLC27A2 | Very-long-chain acyl-CoA synthetase in peroxisomes | Peroxisomal fatty acid oxidation research |
| SLC27A4 | Acyl-CoA synthetase important for epidermal and systemic lipid metabolism | Skin lipid and metabolic disease models |
| ACSBG1 | Acyl-CoA synthetase for long-chain fatty acids in brain | Neuronal lipid metabolism studies |
| ACSBG2 | Acyl-CoA synthetase expressed in testis and brain | Reproductive and neural lipid research |
| ACSS1 | Acetyl-CoA synthetase in mitochondria | Acetyl-CoA and energy metabolism studies |
| ACSS2 | Acetyl-CoA synthetase in cytosol and nucleus | Cancer metabolism and gene regulation research |
| CPT1A | Carnitine palmitoyltransferase importing acyl-CoA into mitochondria | Beta-oxidation and fatty acid oxidation disorders |
| HADHA | Mitochondrial trifunctional protein subunit in beta-oxidation | Inherited fatty acid oxidation disease models |
| ACADM | Medium-chain acyl-CoA dehydrogenase in beta-oxidation | MCAD deficiency and newborn screening research |
| ACADVL | Very-long-chain acyl-CoA dehydrogenase | VLCAD deficiency and cardiomyopathy studies |
| AMPK | Energy sensor regulated by long-chain fatty acyl-CoA esters | Metabolic signaling and insulin sensitivity research |
| ZDHHC enzymes | Palmitoyltransferases using fatty acyl-CoA for protein acylation | Protein palmitoylation and membrane trafficking studies |
How Is fatty-acyl-CoA biosynthetic process Regulated?
Fatty-acyl-CoA biosynthetic process is regulated at multiple levels. Substrate availability and fatty acid transport influence flux into the pathway, while acyl-CoA synthetase expression and localization determine which fatty acids are activated and where. Long-chain fatty acyl-CoA esters act as signaling molecules that regulate metabolism and gene expression, and they are sensed by AMPK, coupling acyl-CoA levels to cellular energy status. Malonyl-CoA, a product of fatty acid synthesis, inhibits fatty acid oxidation and contributes to the regulation of acyl-CoA partitioning, with implications for insulin resistance in skeletal muscle. Together, these mechanisms allow the cell to balance fatty-acyl-CoA production with oxidation, storage, and signaling demands.
fatty-acyl-CoA biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACADM | Medium-chain acyl-CoA dehydrogenase deficiency | Knockout cell model with acylcarnitine profiling |
| ACADVL | Very-long-chain acyl-CoA dehydrogenase deficiency | Point-mutation knock-in for missense variants |
| SLC27A2 | Peroxisomal fatty acid oxidation defects | Knockout in hepatocyte or fibroblast lines |
| ACSL4 | Ferroptosis sensitivity in cancer | Knockout and overexpression models with lipid peroxidation assays |
| CPT1A | Fatty acid oxidation disorders | Knockout with metabolic flux analysis |
Inherited fatty acid oxidation disorders
Defects in the activation and subsequent oxidation of fatty acids cause a group of inherited metabolic diseases, including acyl-CoA dehydrogenase deficiencies and mitochondrial beta-oxidation disorders. Peroxisomal acyl-CoA synthetase defects impair very-long-chain fatty acid oxidation and contribute to peroxisomal disease phenotypes. These conditions illustrate how disruption of fatty-acyl-CoA biosynthesis and utilization leads to severe metabolic consequences.
Insulin resistance and type 2 diabetes
Accumulation of malonyl-CoA and long-chain fatty acyl-CoA in skeletal muscle has been linked to impaired insulin signaling and insulin resistance. Because fatty-acyl-CoA esters participate in signaling as well as metabolism, altered acyl-CoA biosynthesis can contribute to metabolic dysfunction in obesity and type 2 diabetes. Studying these links requires careful measurement of acyl-CoA species and pathway flux.
Cancer metabolism
Cancer cells frequently reprogram lipid metabolism, and acyl-CoA synthetases contribute to the activation of fatty acids used for membrane synthesis and energy production. ACSL family enzymes have been implicated in tumor lipid metabolism and in pathways such as ferroptosis that depend on acyl-CoA-derived lipids. These observations make fatty-acyl-CoA biosynthesis a target of interest in cancer metabolism research.
Neurodegeneration and brain lipid metabolism
Brain-enriched acyl-CoA synthetases such as ACSBG1 and ACSL6 support neuronal lipid metabolism, and disruptions in fatty acid activation may affect neuronal function. Long-chain fatty acyl-CoA esters also influence signaling pathways relevant to neuronal energy homeostasis. These connections motivate research into acyl-CoA metabolism in neurodegenerative and neurodevelopmental contexts.
From fatty-acyl-CoA biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ACSL1 impair fatty acid oxidation? | CRISPR knockout in hepatocyte or myocyte lines |
| Does a patient missense variant alter acyl-CoA synthetase activity? | Point-mutation knock-in expressing the variant |
| Can a tag be used to localize acyl-CoA synthetase? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of SLC27A2 increase very-long-chain acyl-CoA? | Overexpression cell model with lipidomics |
| How does AMPK respond to acyl-CoA changes? | Knockout or overexpression with AMPK activity assays |
| Which genes modify acyl-CoA pools genome-wide? | CRISPR library screening with metabolic readouts |
How to Study the fatty-acyl-CoA biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Acyl-CoA synthetase activity assay | Enzymatic conversion of fatty acid to acyl-CoA | Validation of ACSL/SLC27A knockout or mutant lines |
| LC-MS lipidomics | Quantities of individual fatty-acyl-CoA species | Metabolic phenotyping of CRISPR models |
| Seahorse respiration | Mitochondrial oxidation of fatty acids | Beta-oxidation capacity in knockout cells |
| Acylcarnitine profiling | Downstream oxidation intermediates | Diagnosis and modeling of fatty acid oxidation disorders |
| AMPK activity assay | Energy-sensing kinase response to acyl-CoA | Signaling studies with acyl-CoA perturbations |
| Palmitoylation assay | Protein acylation using fatty acyl-CoA | Protein modification and trafficking research |
| CRISPR library screening | Genes modifying acyl-CoA-related phenotypes | Pathway discovery and target identification |
| RNA-seq / proteomics | Expression changes in lipid metabolic genes | Functional enrichment of GO:0046949 annotations |
Measuring acyl-CoA synthetase activity
Enzymatic assays using radiolabeled or fluorescent fatty acid substrates allow direct measurement of acyl-CoA synthetase activity in cell lysates and membrane fractions. These assays are foundational for validating CRISPR models of ACSL and SLC27A genes.
Lipidomics and acyl-CoA profiling
Mass spectrometry-based lipidomics can quantify individual fatty-acyl-CoA species and reveal how genetic perturbations shift the acyl-CoA pool. This approach is essential for linking genotype to metabolic phenotype in knockout and overexpression models.
Metabolic flux and oxidation assays
Seahorse respiration, radiolabeled fatty acid oxidation, and acylcarnitine profiling measure how acyl-CoA biosynthesis feeds into beta-oxidation. These methods are widely used to characterize inherited fatty acid oxidation disorders.
Signaling and interaction assays
AMPK activity assays, co-immunoprecipitation, and palmitoylation assays reveal how fatty-acyl-CoA esters participate in signaling and protein modification. Such experiments connect acyl-CoA metabolism to broader cellular regulation.
How CRISPR Can Be Used to Study GO:0046949 fatty-acyl-CoA biosynthetic process
Knockout
CRISPR knockout of acyl-CoA synthetase genes such as ACSL1 or SLC27A2 allows researchers to test whether fatty-acyl-CoA biosynthesis is required for oxidation, lipid synthesis, or signaling. Knockout models are typically validated with enzymatic activity assays and lipidomics.
Point Mutation
Point-mutation knock-in can model patient-derived missense variants in acyl-CoA synthetase or beta-oxidation genes, enabling assessment of catalytic activity and substrate specificity. These models are valuable for inherited metabolic disease research.
Knock-in
Tagged knock-in of endogenous acyl-CoA synthetases with fluorescent or affinity tags supports localization and interaction studies under native regulation. Knock-in of reporter cassettes can also be used to monitor pathway activity.
Overexpression
Overexpression of acyl-CoA synthetases or fatty acid transport proteins increases flux through fatty-acyl-CoA biosynthesis and can reveal downstream metabolic and signaling consequences. Overexpression models are useful for testing sufficiency of a candidate gene.
How EDITGENE Supports fatty-acyl-CoA biosynthetic process Research
Researchers studying fatty-acyl-CoA biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in acyl-CoA production, partitioning, or downstream signaling. Rigorous causal inference requires well-controlled genetic models in relevant cell backgrounds, combined with quantitative metabolic readouts.
Contact EDITGENE today to design your custom CRISPR model for fatty-acyl-CoA biosynthetic process research.
Frequently Asked Questions About fatty-acyl-CoA biosynthetic process
What is fatty-acyl-CoA biosynthetic process?
It is the biological process (GO:0046949) by which fatty acids are activated through thioester linkage to coenzyme A, forming fatty-acyl-CoA molecules.
What genes are involved in fatty-acyl-CoA biosynthetic process?
Key genes include ACSL1, ACSL3, ACSL4, ACSL5, ACSL6, SLC27A1, SLC27A2, SLC27A4, ACSBG1, ACSBG2, ACSS1, and ACSS2, which encode acyl-CoA synthetases and related enzymes.
What enzymes catalyze fatty-acyl-CoA biosynthesis?
Acyl-CoA synthetases catalyze the ATP-dependent ligation of fatty acids to coenzyme A, forming fatty-acyl-CoA thioesters.
Why is fatty-acyl-CoA important for metabolism?
Fatty-acyl-CoA is required for beta-oxidation, lipid synthesis, protein acylation, and signaling, making it central to energy and lipid metabolism.
How is fatty-acyl-CoA biosynthetic process regulated?
It is regulated by substrate availability, enzyme expression and localization, and by signaling through AMPK and malonyl-CoA.
What diseases are linked to fatty-acyl-CoA metabolism?
Inherited fatty acid oxidation disorders, insulin resistance, peroxisomal disease, and cancer metabolism have been linked to acyl-CoA pathway dysfunction.
How do you measure acyl-CoA synthetase activity?
Enzymatic assays with labeled fatty acid substrates and mass spectrometry-based acyl-CoA profiling are commonly used.
Can CRISPR be used to study fatty-acyl-CoA biosynthesis?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of acyl-CoA synthetase and related genes.
What is the GO ID for fatty-acyl-CoA biosynthetic process?
The GO ID is GO:0046949, a biological_process term in the Gene Ontology.
What are synonyms for fatty-acyl-CoA biosynthetic process?
Synonyms include fatty-acyl-CoA anabolism, fatty-acyl-CoA biosynthesis, fatty acyl CoA biosynthetic process, fatty-acyl-CoA formation, and fatty-acyl-CoA synthesis.
Conclusion
Fatty-acyl-CoA biosynthetic process (GO:0046949) is a central metabolic process that activates fatty acids for oxidation, lipid synthesis, protein acylation, and signaling. Its enzymes, including the ACSL and SLC27A families, are implicated in inherited metabolic disorders, insulin resistance, and cancer metabolism, making the pathway a persistent focus of biomedical research. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with enzymatic and lipidomic readouts, provide powerful tools for dissecting the causal roles of individual genes in this pathway. Researchers can leverage these approaches to connect genotype to metabolic phenotype and to identify new therapeutic targets.
References
- 1. Watkins PA et al.. 2012. Peroxisomal acyl-CoA synthetases.. Biochim Biophys Acta 1822(9):1411-20 PMID: 22366061
- 2. Grevengoed TJ et al.. 2014. Acyl-CoA metabolism and partitioning.. Annu Rev Nutr 34:1-30 PMID: 24819326
- 3. Lee CJ et al.. 2022. Bivalent recognition of fatty acyl-CoA by a human integral membrane palmitoyltransferase.. Proc Natl Acad Sci U S A 119(7) PMID: 35140179
- 4. Wanders RJ et al.. 1999. Disorders of mitochondrial fatty acyl-CoA beta-oxidation.. J Inherit Metab Dis 22(4):442-87 PMID: 10407780
- 5. Ruderman NB et al.. 1998. Malonyl CoA, long chain fatty acyl CoA and insulin resistance in skeletal muscle.. J Basic Clin Physiol Pharmacol 9(2-4):295-308 PMID: 10212840
- 6. Füllekrug J et al.. 2016. Measurement of Long-Chain Fatty Acyl-CoA Synthetase Activity.. Methods Mol Biol 1376:43-53 PMID: 26552674
- 7. Faergeman NJ et al.. 1997. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling.. Biochem J 323 ( Pt 1)(Pt 1):1-12 PMID: 9173866
- 8. Desjardins EM et al.. 2025. Sensing of Long-Chain Fatty Acyl-CoA Esters by AMPK.. Methods Mol Biol 2882:121-137 PMID: 39992507
